These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9949952)

  • 41. The Epstein-Barr virus (EBV) major envelope glycoprotein gp350/220-specific antibody reactivities in the sera of patients with different EBV-associated diseases.
    Xu J; Ahmad A; Blagdon M; D'Addario M; Jones JF; Dolcetti R; Vaccher E; Prasad U; Menezes J
    Int J Cancer; 1998 Oct; 79(5):481-6. PubMed ID: 9761116
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of four commercially available Epstein-Barr virus enzyme immunoassays with an immunofluorescence assay as the reference method.
    Gärtner BC; Hess RD; Bandt D; Kruse A; Rethwilm A; Roemer K; Mueller-Lantzsch N
    Clin Diagn Lab Immunol; 2003 Jan; 10(1):78-82. PubMed ID: 12522043
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evidence-based approach for interpretation of Epstein-Barr virus serological patterns.
    Klutts JS; Ford BA; Perez NR; Gronowski AM
    J Clin Microbiol; 2009 Oct; 47(10):3204-10. PubMed ID: 19656988
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Seroepidemiological Study of Epstein-Barr Virus in Different Population Groups in Croatia.
    Beader N; Kolarić B; Slačanac D; Tabain I; Vilibić-Čavlek T
    Isr Med Assoc J; 2018 Feb; 20(2):86-90. PubMed ID: 29431301
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of antibodies to the Epstein-Barr virus immediate early gene product ZEBRA by a new enzyme-linked immunosorbent assay.
    Yamauchi Y; Tachiband Y; Maeda A; Wakiguchi H; Usui M; Kurata T; Sairenji T
    Intervirology; 1998; 41(6):278-84. PubMed ID: 10325538
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnosis of recent primary rubella virus infections: significance of glycoprotein-based IgM serology, IgG avidity and immunoblot analysis.
    Wandinger KP; Saschenbrecker S; Steinhagen K; Scheper T; Meyer W; Bartelt U; Enders G
    J Virol Methods; 2011 Jun; 174(1-2):85-93. PubMed ID: 21513745
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnostic Performance and Comparative Evaluation of the Architect, Liaison, and Platelia Epstein-Barr Virus Antibody Assays.
    Park Y; Park BG; Ha J; Kim HS
    Ann Lab Med; 2018 Sep; 38(5):458-465. PubMed ID: 29797817
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnostic evaluation of a new panel of assays for Epstein-Barr virus serology.
    Radtke M; Gärtner B; Franke D
    Clin Lab; 2007; 53(3-4):149-50. PubMed ID: 17447650
    [No Abstract]   [Full Text] [Related]  

  • 49. Diagnostic significance of immunoglobulin G avidity in symptomatic and asymptomatic West Nile virus infection.
    Vilibic-Cavlek T; Kristofic B; Savic V; Kolaric B; Barbic L; Tabain I; Peric L; Sabadi D; Miklausic B; Potocnik-Hunjadi T; Zember S; Stevanovic V; Listes E; Savini G
    Rev Soc Bras Med Trop; 2018; 51(5):591-595. PubMed ID: 30304263
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of a pan-reactive hantavirus enzyme immunoassay and of a hantavirus immunoblot for the diagnosis of nephropathia epidemica.
    Schubert J; Tollmann F; Weissbrich B
    J Clin Virol; 2001 Apr; 21(1):63-74. PubMed ID: 11255099
    [TBL] [Abstract][Full Text] [Related]  

  • 51. No evidence for intrathecal IgG synthesis to Epstein Barr virus nuclear antigen-1 in multiple sclerosis.
    Jafari N; van Nierop GP; Verjans GM; Osterhaus AD; Middeldorp JM; Hintzen RQ
    J Clin Virol; 2010 Sep; 49(1):26-31. PubMed ID: 20638898
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diagnosis of infectious mononucleosis caused by Epstein-Barr virus in infants.
    Dohno S; Maeda A; Ishiura Y; Sato T; Fujieda M; Wakiguchi H
    Pediatr Int; 2010 Aug; 52(4):536-40. PubMed ID: 20113421
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Investigation of Epstein-Barr virus and herpes simplex virus markers by serological and molecular methods in patients with rheumatoid arthritis and systemic lupus erythematosus].
    Us T; Cetin E; Kaşifoğlu N; Kaşifoğlu T; Akgün Y
    Mikrobiyol Bul; 2011 Oct; 45(4):677-83. PubMed ID: 22090298
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combination of Epstein-Barr virus scaffold (BdRF1/VCA-p40) and small capsid protein (BFRF3/VCA-p18) into a single molecule for improved serodiagnosis of acute and malignant EBV-driven disease.
    Fachiroh J; Stevens SJ; Haryana SM; Middeldorp JM
    J Virol Methods; 2010 Oct; 169(1):79-86. PubMed ID: 20621126
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Evaluation of IgG-IgM antibodies against the Epstein-Barr virus nuclear antigen (EBNA-1) using ELISA].
    Martínez Zapico R; Sobejano L; Llamazares I; Ladrón de Guevara C
    Enferm Infecc Microbiol Clin; 1992 May; 10(5):281-3. PubMed ID: 1327168
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Study on the serological diagnosis of Epstein-Barr virus among patients with mononucleosis].
    Liu CY; Yan J; Liu YY; Xie ZD
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Sep; 28(9):898-900. PubMed ID: 18251276
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Seroepidemiology of EBV and interpretation of the "isolated VCA IgG" pattern.
    De Paschale M; Agrappi C; Manco MT; Mirri P; Viganò EF; Clerici P
    J Med Virol; 2009 Feb; 81(2):325-31. PubMed ID: 19107979
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serological cross reactivity to CMV and EBV causes problems in the diagnosis of acute hepatitis E virus infection.
    Hyams C; Mabayoje DA; Copping R; Maranao D; Patel M; Labbett W; Haque T; Webster DP
    J Med Virol; 2014 Mar; 86(3):478-83. PubMed ID: 24402843
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Application of low-avidity immunoglobulin G studies to diagnosis of Epstein-Barr virus infectious mononucleosis.
    de Ory F; Antonaya J; Fernández MV; Echevarría JM
    J Clin Microbiol; 1993 Jun; 31(6):1669-71. PubMed ID: 8315017
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [A comparison of the detection of IgM antibodies against the viral capsid antigen (VCA) of EBV (Epstein-Barr virus) in various groups of patients, using indirect immunofluorescence, indirect ELISA and reverse ELISA. Study of the diagnostic efficacy of the anti-VCA EBV IgM ELISA-VIDITEST kit].
    Pumannová M; Rezbová M; Svecová M; Hrbácková H; Novotná M; Ochotná J; Roubalová K
    Klin Mikrobiol Infekc Lek; 2004 Aug; 10(4):186-90. PubMed ID: 15328576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.